Effectiveness of Gorei-san (TJ-17) for treatment of SSRI-induced nausea and dyspepsia: Preliminary observations

Kazuo Yamada, Gohei Yagi, Shigenobu Kanba

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Selective serotonin reuptake inhibitors (SSRIs) are apt to cause gastrointestinal adverse events such as nausea and dyspepsia. Gorei-san (TJ-17), which is composed of five herbs (Alismatis rhizoma, Atractylodis lanceae rhizoma, Polyporus, Hoelen, and Cinnamomi cortex), is a Japanese herbal medicine that has been used to treat nausea, dry mouth, edema, headache, and dizziness. The authors investigated the efficacy of TJ-17 for patients who experienced nausea or dyspepsia induced by SSRIs. Twenty outpatients who experienced nausea or dyspepsia induced by SSRIs were recruited for the study. Seventeen patients were female, three were male, and patient age ranged from 21 to 74 years (49.8 ± 17.0 years). TJ-17 was added to the previous regimen. Nausea and dyspepsia disappeared completely in nine patients, decreased in four patients, decreased slightly in two patients, and did not change in five patients. No adverse events were associated with the addition of TJ-17 in any patient.

Original languageEnglish
Pages (from-to)112-114
Number of pages3
JournalClinical Neuropharmacology
Volume26
Issue number3
DOIs
Publication statusPublished - May 1 2003
Externally publishedYes

Fingerprint

Dyspepsia
Serotonin Uptake Inhibitors
Nausea
Therapeutics
Polyporus
gorei-san
Herbal Medicine
Dizziness
Headache
Mouth
Edema
Outpatients

All Science Journal Classification (ASJC) codes

  • Pharmacology
  • Clinical Neurology
  • Pharmacology (medical)

Cite this

Effectiveness of Gorei-san (TJ-17) for treatment of SSRI-induced nausea and dyspepsia : Preliminary observations. / Yamada, Kazuo; Yagi, Gohei; Kanba, Shigenobu.

In: Clinical Neuropharmacology, Vol. 26, No. 3, 01.05.2003, p. 112-114.

Research output: Contribution to journalArticle

Yamada, Kazuo ; Yagi, Gohei ; Kanba, Shigenobu. / Effectiveness of Gorei-san (TJ-17) for treatment of SSRI-induced nausea and dyspepsia : Preliminary observations. In: Clinical Neuropharmacology. 2003 ; Vol. 26, No. 3. pp. 112-114.
@article{9d074e2091724f8aaef5a2900011314c,
title = "Effectiveness of Gorei-san (TJ-17) for treatment of SSRI-induced nausea and dyspepsia: Preliminary observations",
abstract = "Selective serotonin reuptake inhibitors (SSRIs) are apt to cause gastrointestinal adverse events such as nausea and dyspepsia. Gorei-san (TJ-17), which is composed of five herbs (Alismatis rhizoma, Atractylodis lanceae rhizoma, Polyporus, Hoelen, and Cinnamomi cortex), is a Japanese herbal medicine that has been used to treat nausea, dry mouth, edema, headache, and dizziness. The authors investigated the efficacy of TJ-17 for patients who experienced nausea or dyspepsia induced by SSRIs. Twenty outpatients who experienced nausea or dyspepsia induced by SSRIs were recruited for the study. Seventeen patients were female, three were male, and patient age ranged from 21 to 74 years (49.8 ± 17.0 years). TJ-17 was added to the previous regimen. Nausea and dyspepsia disappeared completely in nine patients, decreased in four patients, decreased slightly in two patients, and did not change in five patients. No adverse events were associated with the addition of TJ-17 in any patient.",
author = "Kazuo Yamada and Gohei Yagi and Shigenobu Kanba",
year = "2003",
month = "5",
day = "1",
doi = "10.1097/00002826-200305000-00002",
language = "English",
volume = "26",
pages = "112--114",
journal = "Clinical Neuropharmacology",
issn = "0362-5664",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - Effectiveness of Gorei-san (TJ-17) for treatment of SSRI-induced nausea and dyspepsia

T2 - Preliminary observations

AU - Yamada, Kazuo

AU - Yagi, Gohei

AU - Kanba, Shigenobu

PY - 2003/5/1

Y1 - 2003/5/1

N2 - Selective serotonin reuptake inhibitors (SSRIs) are apt to cause gastrointestinal adverse events such as nausea and dyspepsia. Gorei-san (TJ-17), which is composed of five herbs (Alismatis rhizoma, Atractylodis lanceae rhizoma, Polyporus, Hoelen, and Cinnamomi cortex), is a Japanese herbal medicine that has been used to treat nausea, dry mouth, edema, headache, and dizziness. The authors investigated the efficacy of TJ-17 for patients who experienced nausea or dyspepsia induced by SSRIs. Twenty outpatients who experienced nausea or dyspepsia induced by SSRIs were recruited for the study. Seventeen patients were female, three were male, and patient age ranged from 21 to 74 years (49.8 ± 17.0 years). TJ-17 was added to the previous regimen. Nausea and dyspepsia disappeared completely in nine patients, decreased in four patients, decreased slightly in two patients, and did not change in five patients. No adverse events were associated with the addition of TJ-17 in any patient.

AB - Selective serotonin reuptake inhibitors (SSRIs) are apt to cause gastrointestinal adverse events such as nausea and dyspepsia. Gorei-san (TJ-17), which is composed of five herbs (Alismatis rhizoma, Atractylodis lanceae rhizoma, Polyporus, Hoelen, and Cinnamomi cortex), is a Japanese herbal medicine that has been used to treat nausea, dry mouth, edema, headache, and dizziness. The authors investigated the efficacy of TJ-17 for patients who experienced nausea or dyspepsia induced by SSRIs. Twenty outpatients who experienced nausea or dyspepsia induced by SSRIs were recruited for the study. Seventeen patients were female, three were male, and patient age ranged from 21 to 74 years (49.8 ± 17.0 years). TJ-17 was added to the previous regimen. Nausea and dyspepsia disappeared completely in nine patients, decreased in four patients, decreased slightly in two patients, and did not change in five patients. No adverse events were associated with the addition of TJ-17 in any patient.

UR - http://www.scopus.com/inward/record.url?scp=0038051869&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0038051869&partnerID=8YFLogxK

U2 - 10.1097/00002826-200305000-00002

DO - 10.1097/00002826-200305000-00002

M3 - Article

C2 - 12782911

AN - SCOPUS:0038051869

VL - 26

SP - 112

EP - 114

JO - Clinical Neuropharmacology

JF - Clinical Neuropharmacology

SN - 0362-5664

IS - 3

ER -